Diarrhea Caused By Circulating Agents

Gastroenterology Clinics of North America

Volumn 41, Issue 3, 2012, Pages 603-610

  Fabian, Elisabeth ^a   Kump, Patrizia ^a   Krejs, Guenter J ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Carcinoid syndrome; Endocrine diarrhea; Neuroendocrine tumors; Pancreatic cholera; Secretory diarrhea

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CALCITONIN; GASTRIN; NEUROKININ A; NEUROPEPTIDE K; SEROTONIN; SUBSTANCE P;

CARCINOID SYNDROME; DIARRHEA; DISEASE ASSOCIATION; HUMAN; HYPERTHYROIDISM; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SOMATOSTATINOMA; SYSTEMIC MASTOCYTOSIS; THYROID MEDULLARY CARCINOMA; VERNER MORRISON SYNDROME; ZOLLINGER ELLISON SYNDROME;

CALCITONIN; CARCINOMA, MEDULLARY; DIARRHEA; GASTRINOMA; HISTAMINE RELEASE; HUMANS; HYPERTHYROIDISM; MALIGNANT CARCINOID SYNDROME; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; PANCREATIC NEOPLASMS; PANCREATIC POLYPEPTIDE; SOMATOSTATIN; SOMATOSTATINOMA; THYROID NEOPLASMS; VIPOMA; ZOLLINGER-ELLISON SYNDROME;

EID: 84865359792     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2012.06.008     Document Type: Review

References (46)

1. Krejs G.J. Diarrhea. Cecil. Textbook of medicine 1992, 680-687. W.B. Saunders, Philadelphia. 19th edition. J.B. Wyngaarden, L.H. Smith (Eds.).
2. Krejs G.J., Hendler R.S., Fordtran J.S. Diagnostic and pathophysiologic studies in patients with chronic diarrhea. Secretory diarrhea 1980, 141-151. American Physiological Society, Bethesda (MD). M. Field (Ed.).
3. Bridges R.J., Rummel W. Mechanistic basis of alterations in mucosal water and electrolyte transport. Clin Gastroenterol 1986, 15:491-506.
4. Field M. Regulation of small intestinal ion transport by cyclic nucleotides and calcium. Secretory diarrhea 1980, 21-30. American Physiological Society, Bethesda (MD). M. Field (Ed.).
5. Field M. Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest 2003, 111:931-943.
6. Krejs G.J. Secretory diarrhea. Triangle 1988, 27:143-148.
7. Jones S.L., Blikslager A.T. Role of the enteric nervous system in the pathophysiology of secretory diarrhea. J Vet Intern Med 2002, 16:222-228.
8. Krejs G.J. VIPoma Syndrome. Am J Gastroenterol 1987, 82:38-48.
9. Verner J.V., Morrison A.B. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 1958, 25:374-380.
10. Matsumoto K.K., Peter J.B., Schultze R.G., et al. Watery diarrhea and hypokalemia associated with pancreatic islet cell adenoma. Gastroenterology 1966, 50:231-242.
11. Bloom S.R., Polak J.M., Pearse A.G.E. Vasoactive intestinal peptide and watery-diarrrhea syndrome. Lancet 1973, 2:14-16.
12. Said S.I., Mutt V. Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature 1970, 225:863-864.
13. Said S.I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science 1970, 169:1217-1218.
14. Said S.I., Mutt V. Isolation from porcine intestinal wall of a vasoactive octacosapeptide related to secretin and glucagon. Eur J Biochem 1972, 28:199-204.
15. Krejs G.J., Barkley R.M., Read N.W., et al. Intestinal secretion induced by vasoactive intestinal polypeptide. A comparison with choleratoxin in the canine jejunum in vivo. J Clin Invest 1978, 61:1337-1345.
16. Krejs G.J., Fordtran J.S., Bloom S.R., et al. Effect of VIP infusion on water and ion transport in the human jejunum. Gastroenterology 1980, 78:722-727.
17. Krejs G.J. Effect of VIP infusion on water and electrolyte transport in the human intestine. Vasoactive intestinal peptide 1982, 193-200. Raven Press, New York. S.I. Said (Ed.).
18. Kane M.G., O'Dorisio T.M., Krejs G.J. Intravenous VIP infusion causes secretory diarrhea in man. N Engl J Med 1983, 309:1482-1485.
19. Krejs G.J., Kane M.G., O'Dorisio T.M. VIP and the pancreatic cholera syndrome. N Engl J Med 1984, 310:1465-1466.
20. Santangelo W.C., O'Dorisio T.M., Kim J.G., et al. Effect of synthetic somatostatin analogue on intestinal water and ion transport in pancreatic cholera syndrome. Ann Intern Med 1985, 103:364-367.
21. Santangelo W.C., O'Dorisio T.M., Kim J.G., et al. VIPoma syndrome: effect of a synthetic somatostatin analogue. Scand J Gastroenterol 1986, 21(Suppl 119):87-90.
22. Read N.W., Read M.G., Krejs G.J., et al. A report of five patients with large-volume secretory diarrhea but no evidence of endocrine tumor or laxative abuse. Dig Dis Sci 1982, 27:193-201.
23. Santangelo W.C., Dueno M.I., Krejs G.J. Pseudopancreatic cholera. Effect of a synthetic somatostatin analogue. Am J Med 1987, 82(Suppl 5B):84-87.
24. Oberndorfer S. Karzinoide Tumore des Duenndarms. Frankf Z Pathol 1907, 1:426-432.
25. Modlin I.M., Lye K.D., Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003, 97:934-959.
26. Arnold R., Wilke A., Rinke A., et al. Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors. Clin Gastroenterol Hepatol 2008, 6:820-827.
27. Davis G.R., Camp R.C., Raskin P., et al. Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome. Gastroenterology 1980, 78:346-349.
28. Modlin I.M., Pavel M., Kidd M., et al. Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumors. Aliment Pharmacol Ther 2010, 31:169-188.
29. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors Part 1-Stomach, Duodenum and Pancreas. Neuroendocrinology 2006, 84:151-216.
30. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors Part 2-Midgut and Hindgut Tumors. Neuroendocrinology 2008, 87:1-64.
31. Zollinger R.M., Ellison E.H. Primary peptic ulceracion of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 1955, 142:709-728.
32. Rambaud J.C., Modigliani R., Emonts P., et al. Fluid secretion in the duodenum and intestinal handling of water and electrolytes in Zollinger-Ellision syndrome. Dig Dis 1978, 23:1089-1097.
33. Wright H.K., Hersh T., Floch M.H., et al. Impaired absorption in the Zollinger-Ellison syndrome independent of gastric hypersecretion. Am J Surg 1970, 119:250-253.
34. Jensen R.T. Pancreatic endocrine tumors: recent advances. Ann Oncol 1999, 10(Suppl 4):S170-S176.
35. Warner R.R. Enteroendocrine tumors other than carcinoid: a review of clinically significant advances. Gastroenterology 2005, 128:1668-1684.
36. Gray I.K., Brannan P., Juan D., et al. Ion transport changes during calcitonin-induced intestinal secretion in man. Gastroenterology 1976, 71:392-398.
37. Rambaud J.C., Hautefeuille M., Ruskone A., et al. Diarrhea due to circulating agents. Clin Gastroenterol 1986, 15:603-629.
38. Mullerpatan P.M., Joshi S.R., Shah R.C., et al. Calcitonin-secreting tumor of the pancreas. Dig Surg 2004, 21:321-324.
39. Jarufe N.P., Coldham C., Orug T., et al. Neuroendocrine tumors of the pancreas: predictors of survival after surgical treatment. Dig Surg 2005, 22:157-162.
40. Krejs G.J., Orci L., Conlon J.M., et al. Somatostatinoma syndrome: biochemical, morphologic and clinical features. N Engl J Med 1979, 301:285-292.
41. Krejs G.J., Browne R., Raskin P. Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water and electrolytes. Gastroenterology 1980, 78:26-31.
42. Bredfeldt J.E., O'Laughlin J.C., Burham J.B., et al. Malabsorption and gastric hypersecretion in systemic mastocytosis. Am J Gastroenterol 1980, 74:133-137.
43. Lundqvist G., Krause U., Larsson L.I., et al. A pancreatic-polypeptide-producing tumor associated with the WDHA Syndrome. Scand J Gastroenterol 1978, 13:715-718.
44. Adrian T.E., Uttenthal L.O., Williams S.J., et al. Secretion of pancreatic polypeptide in patients with pancreatic endocrine tumors. N Engl J Med 1986, 315:287-291.
45. van Beek A.P., de Haas E.R., van Vloten W.A. The gulcagonoma syndrome and necrolytic migratory erythema: a clinical review. Eur J Endocrinol 2004, 151:531-537.
46. Bayliss W.M., Starling E. The mechanism of pancreatic secretion. J Physiol 1902, 28:325-353.